Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein

被引:3
|
作者
Le Bayon, Jean-Christophe [1 ]
Terrier, Olivier [1 ]
Cartet, Gaelle [1 ]
Lina, Bruno [1 ]
Rosa-Calatrava, Manuel [1 ]
机构
[1] Univ Lyon 1, Fac Med Laennec, Equipe VirCell, Lab Virol & Pathol Humaines VirPath,UCBL HCL EA46, F-69372 Lyon 08, France
关键词
Paramyxoviridae; Paramyxovirus; Parainfluenza virus; Fusion protein; Hemagglutinin-neuraminidase protein; PARAMYXOVIRUS FUSION; MEMBRANE-FUSION; F-PROTEIN; ENTRY; MECHANISM; DISEASE; REGIONS; STALK;
D O I
10.1007/s11262-013-0932-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Human parainfluenza viruses (hPIV) are pathogens responsible for upper and lower respiratory tract infections. We previously described clinical variant strains of hPIV-2 that display unusual large syncytial cytopathic effects. Their molecular characterization revealed a recurrent conserved specific amino acid substitution: A96T in the F2 subunit of the fusion glycoprotein F. The objective of this study was to investigate the contribution of this A96T substitution to the specific hyperfusogenic properties of the hPIV-2 variant strains. Based on a transient expression strategy, quantification of cell-cell fusion assays, and flow cytometry, we have shown that the A96T mutation strongly alters the fusogenic properties of F hPIV-2, highlighting this key residue in the F2 subunit and its possible role in fusion regulation. This work highlights the benefits of monitoring genetic and phenotypic changes of circulating strains to complete our understanding of Paramyxovirus fusion and related pathogenesis.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 50 条
  • [1] Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein
    Jean-Christophe Le Bayon
    Olivier Terrier
    Gaëlle Cartet
    Bruno Lina
    Manuel Rosa-Calatrava
    Virus Genes, 2013, 47 : 365 - 369
  • [2] Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants
    Terrier, O.
    Cartet, G.
    Ferraris, O.
    Morfin, F.
    Thouvenot, D.
    Hong, S. S.
    Lina, B.
    JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (01) : 86 - 92
  • [3] Identification of Human Parainfluenza Virus Type 2 (HPIV-2) V Protein Amino Acid Residues That Reduce Binding of V to MDA5 and Attenuate HPIV-2 Replication in Nonhuman Primates
    Schaap-Nutt, Anne
    Higgins, Caraline
    Amaro-Carambot, Emerito
    Nolan, Sheila M.
    D'Angelo, Christopher
    Murphy, Brian R.
    Collins, Peter L.
    Schmidt, Alexander C.
    JOURNAL OF VIROLOGY, 2011, 85 (08) : 4007 - 4019
  • [4] Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine
    Mackow, Natalie
    Amaro-Carambot, Emerito
    Liang, Bo
    Surman, Sonja
    Lingemann, Matthias
    Yang, Lijuan
    Collins, Peter L.
    Munir, Shirin
    JOURNAL OF VIROLOGY, 2015, 89 (20) : 10319 - 10332
  • [5] MOLECULAR-CLONING AND SEQUENCE-ANALYSIS OF THE FUSION GLYCOPROTEIN GENE OF HUMAN PARAINFLUENZA VIRUS TYPE-2
    HU, XL
    COMPANS, RW
    MATSUOKA, Y
    RAY, R
    VIROLOGY, 1990, 179 (02) : 915 - 920
  • [6] Human parainfluenza virus type 2 (HPIV2) induced host ADAM8 expression in human salivary adenocarcinoma cell line (HSY) during cell fusion
    Guo-Feng Ma
    Simo Miettinen
    Pauliina Porola
    Klaus Hedman
    Jari Salo
    Yrjö T Konttinen
    BMC Microbiology, 9
  • [7] Molecular Evolution of the Fusion (F) Genes in Human Parainfluenza Virus Type 2
    Shirai, Tatsuya
    Mizukoshi, Fuminori
    Kimura, Ryusuke
    Matsuoka, Rina
    Sada, Mitsuru
    Shirato, Kazuya
    Ishii, Haruyuki
    Ryo, Akihide
    Kimura, Hirokazu
    MICROORGANISMS, 2025, 13 (02)
  • [8] Human parainfluenza virus type 2 (HPIV2) induced host ADAM8 expression in human salivary adenocarcinoma cell line (HSY) during cell fusion
    Ma, Guo-Feng
    Miettinen, Simo
    Porola, Pauliina
    Hedman, Klaus
    Salo, Jari
    Konttinen, Yrjo T.
    BMC MICROBIOLOGY, 2009, 9
  • [9] Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV
    Jones, Bart
    Zhan, Xiaoyan
    Mishin, Vasiliy
    Slobod, Karen S.
    Surman, Sherri
    Russell, Charles J.
    Portner, Allen
    Hurwitz, Julia L.
    VACCINE, 2009, 27 (12) : 1848 - 1857
  • [10] IDENTIFICATION AND CHARACTERIZATION OF FUSION AND PROCESSING DOMAINS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 2 ENVELOPE GLYCOPROTEIN
    FREED, EO
    MYERS, DJ
    JOURNAL OF VIROLOGY, 1992, 66 (09) : 5472 - 5478